Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07531498 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Muscle Aging Phenotypes in Childhood Cancer Survivors

StatusRecruiting
PhaseNot specified
Started2026-09-14
View on ClinicalTrials.gov ↗

Amendment history

2026-08-31
notable
Study Status, Contacts/Locations v7
Trial started: 2026-09-14 (last estimated 2026-10-01)
Recruitment opened
Study sitesdetails revised at 1 of 1 site
2026-07-24
minor
Study Status, Eligibility v6
Eligibility criteria+302 characters
[...] al guardian/representative to give written informed consent. Presence of known radiation-induced nerve injury. Prescence of pre-existing neurologic (non-cancer related) or who develop chronic neurologic disorders (i.e. Charcot Marie Tooth Disease, Downs, congenital brain injury). Participation on a lifestyle or medication clinical trial within the past 1 yea [...]
2026-07-14
minor
Study Identification, Study Status, Sponsor/Collaborators v5
Collaborators+31 characters
National Cancer Institute (NCI)
2026-06-22
minor
Study Status v4
Start date2026-07→2026-10-01
2026-06-15
minor
Study Status v3
Start date2026-05→2026-07
2026-04-21
critical
Study Status, Contacts/Locations v2
Primary endpoint(s) modified3 entries, revised
WasContributions of intramyocellular and extramyocellular fat to reduced muscle health in childhood cancer survivors., Contributions of mitochondrial function to reduced muscle function in childhood cancer survivors., Contributions of neuromotor function to reduced muscle health in childhood cancer survivors
NowCreatinine recovery post exercise with magnetic resonance imaging (MRI), Intramyocellular and extramyocellular fat fraction in muscle during magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS), Nerve conduction velocity (NCV) at rest and Electromyography (EMG) during submaximal and maximal force generation
Study sitescontacts updated at 1 of 1 site
2026-04-15
minor
Study Status, Outcome Measures v1
Secondary endpoints-268 characters
To identify specific treatment related risk factors for each reduced muscle health endotype. To identify specific chronic disease related risk for each reduced muscle health endotype. To identify specific lifestyle related risk for each reduced muscle health endotype.
Primary endpoints3 entries, revised
ContributionsCreatinine ofrecovery intramyocellularpost exercise with magnetic resonance imaging (MRI) Intramyocellular and extramyocellular fat tofraction reducedin muscle healthduring inmagnetic childhoodresonance cancerimaging survivors.(MRI) and magnetic resonance spectroscopy (MRS) ContributionsNerve ofconduction mitochondrialvelocity function(NCV) toat reducedrest muscleand functionElectromyography in(EMG) childhoodduring cancersubmaximal survivors. Contributionsand ofmaximal neuromotorforce function to reduced muscle health in childhood cancer survivorsgeneration
2026-04-08
minor
Original filing
Childhood cancer survivors experience premature declines in muscle mass, strength, and physical function that contribute to morbidity and early mortality. The biological mechanisms driving these impairments are heterogeneous and poorly understood. This observational study aims to characterize distinct muscle health endotypes in adult survivors of childhood cancer using advanced imaging, neuromuscular testing, and functional assessment. Survivors with reduced muscle health and community controls will undergo multimodal magnetic resonance imaging and spectroscopy, nerve conduction studies, surface electromyography, body composition assessment, and physical performance testing during a single study visit integrated into an ongoing cohort evaluation. Identifying mechanistic endotypes of impaired muscle health will support development of targeted interventions to preserve function and improve long-term outcomes in childhood cancer survivors. Primary Objective: \- Characterize reduced muscle health endotypes in childhood cancer survivors. Secondary Objective: \- Identify specific treatment and lifestyle related risk factors for each reduced muscle health endotype. Exploratory Objective: \- Host germline genetics will be associated with specific muscle endotypes.
Trial Details
NCT Number NCT07531498
Lead Sponsor St. Jude Children's Research Hospital
Collaborators: National Cancer Institute (NCI)
Conditions Muscle Weakness, Low Muscle Mass, Sarcopenia
Enrollment 533 participants
Start Date 2026-09-14
Primary Completion 2030-05 (estimated)
Study Completion 2031-05 (estimated)
Updated on ClinicalTrials.gov 2026-09-16